Task: Answer the multiple choice question.
Question: Which compound exhibits a -2.463\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
[a] Cc1nnsc1-c1onc(C)c1C(=O)O/N=C/c1ccc(Cl)cc1
[b] CCC(C)NC(=O)CSc1nc2ccccc2c(=O)n1Cc1ccc(OC)cc1
Answer: b. CCC(C)NC(=O)CSc1nc2ccccc2c(=O)n1Cc1ccc(OC)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(C)NC(=O)CSc1nc2ccccc2c(=O)n1Cc1ccc(OC)cc1
CCC(C)NC(=O)CSc1nc2ccccc2c(=O)n1Cc1ccc(OC)cc1
N-butan-2-yl-2-[3-[(4-methoxyphenyl)methyl]-4-oxoquinazolin-2-yl]sulfanylacetamide